Cargando…

Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by decreased synaptic transmission and cerebral atrophy with appearance of amyloid plaques and neurofibrillary tangles. Cognitive, functional, and behavioral alterations are commonly associated with the disease. Different pathoph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheong, Siew Lee, Tiew, Jian Kai, Fong, Yi Hang, Leong, How Wan, Chan, Yew Mun, Chan, Zhi Ling, Kong, Ethan Wei Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781592/ https://www.ncbi.nlm.nih.gov/pubmed/36559010 http://dx.doi.org/10.3390/ph15121560

Ejemplares similares

Factors Associated with Dietary Diversity Score among Individuals with Type 2 Diabetes Mellitus
por: Tiew, Kee Fong, et al.
Publicado: (2014)

Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
por: Cummings, Jeffrey L., et al.
Publicado: (2019)

Pharmacotherapy Evolution in Alzheimer’s Disease: Current Framework and Relevant Directions
por: Miculas, Denisa Claudia, et al.
Publicado: (2022)

Combination pharmacotherapy in Alzheimer's disease
por: Mintzer, Jacobo, et al.
Publicado: (2003)

Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy
por: Vallius, Sanna, et al.
Publicado: (2021)

Obesity pharmacotherapy: current status
por: Kumar, Parveen, et al.
Publicado: (2015)

Current and Emerging Pharmacotherapy for Fibromyalgia
por: Tzadok, Roie, et al.
Publicado: (2020)

Current Trends in the Pharmacotherapy of Cataracts
por: Heruye, Segewkal H., et al.
Publicado: (2020)

Current pharmacotherapy of overactive bladder
por: Kreydin, Evgenyi I., et al.
Publicado: (2021)

Impact of Pharmacotherapy on Insomnia in Patients with Alzheimer’s Disease
por: Roland, Joshua P., et al.
Publicado: (2021)

Some Candidate Drugs for Pharmacotherapy of Alzheimer’s Disease
por: Miziak, Barbara, et al.
Publicado: (2021)

Efficacy of pharmacotherapy and non-pharmacotherapy of Alzheimer dementia: A protocol for systematic review and meta-analysis
por: Boongird, Chitima, et al.
Publicado: (2022)

Pharmacotherapy of Sexual Dysfunctions : Current Status
por: Avasthi, Ajith, et al.
Publicado: (2004)

Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement
por: Stanciu, Gabriela Dumitrita, et al.
Publicado: (2019)

Current and Emerging Pharmacotherapies for Primary CNS Lymphoma
por: Prodduturi, Prathima, et al.
Publicado: (2012)

Pharmacotherapies for Obesity: Past, Current, and Future Therapies
por: Ioannides-Demos, Lisa L., et al.
Publicado: (2011)

Obesity Pharmacotherapy: Current Perspectives and Future Directions
por: Misra, Monika
Publicado: (2013)

Pharmacotherapy for uveitis: current management and emerging therapy
por: Barry, Robert J, et al.
Publicado: (2014)

Current Long-Term Pharmacotherapies for the Management of Obesity
por: Kim, Bo-Yeon, et al.
Publicado: (2020)

Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty
por: Husna Ibrahim, Nurul, et al.
Publicado: (2020)

Multi-Foci Laser Separation of Sapphire Wafers with Partial Thickness Scanning
por: Lye, Celescia Siew Mun, et al.
Publicado: (2022)

Current issues around the pharmacotherapy of ADHD in children and adults
por: Meijer, Willemijn M., et al.
Publicado: (2009)

AB028. Current status of pharmacotherapy for erectile dysfunction
por: Adaikan, P Ganesan
Publicado: (2016)

Novel Pharmacotherapies for Recurrent Pericarditis: Current Options in 2020
por: Tombetti, Enrico, et al.
Publicado: (2020)

Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
por: Garakani, Amir, et al.
Publicado: (2020)

Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
por: Garakani, Amir, et al.
Publicado: (2021)

A fluid model of pulsed direct current planar magnetron discharge
por: Tran, Si Bui Quang, et al.
Publicado: (2023)

In silico hippocampal modeling for multi-target pharmacotherapy in schizophrenia
por: Sherif, Mohamed A., et al.
Publicado: (2020)

Multi-Foci Division of Nonlinear Energy Absorption on Ultrashort Pulse Laser Singulation of Sapphire Wafers
por: Lye, Celescia Siew Mun, et al.
Publicado: (2021)

The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2020)

Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease
por: Lawn, Timothy, et al.
Publicado: (2021)

Guidelines for pharmacotherapy in Alzheimer’s disease – A primer on FDA-approved drugs
por: Varadharajan, Ashvin, et al.
Publicado: (2023)

Novel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon?
por: Das, Arup, et al.
Publicado: (2016)

Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies
por: Faour, Wissam H., et al.
Publicado: (2021)

Molecular Mechanisms and Current Pharmacotherapy of Peyronie’s Disease: A Review
por: Zhang, Fuxun, et al.
Publicado: (2021)

Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential
por: Raghu, Ganesh
Publicado: (2017)

Current and projected burden of heart failure in the Australian adult population: a substantive but still ill-defined major health issue
por: Chan, Yih-Kai, et al.
Publicado: (2016)

Pharmacotherapy for Fibromyalgia
por: Smith, Howard S., et al.
Publicado: (2011)

Antiglaucoma pharmacotherapy
por: Tătaru, CP, et al.
Publicado: (2012)

Pharmacotherapies for COPD
por: Ejiofor, Stan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_t3m5dq15lk8d6bd2p8rtsfvglb